Joseph Ragaz

EMSY Links the BRCA2 Pathway to Sporadic Breast and Ovarian Cancer

Luke Hughes-Davies, Carlos Caldas, David S Yu, 2003, Cell.

Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.

John J Spinelli, Karen Gelmon, J. Spinelli, 2005, Journal of the National Cancer Institute.

Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model.

J. Ragaz, N. Macpherson, A. Brodie, 2004, Journal of the National Cancer Institute.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Y Wang, Mike Clarke, Donald A. Berry, 2005, The Lancet.

Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index

Carlos Caldas, Ian O. Ellis, Sarah E. Pinder, 2006, Clinical Cancer Research.

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

Mike Clarke, Yasuo Ohashi, Michael Gnant, 2018, The Lancet. Oncology.

Tamoxifen for early breast cancer: an overview of the randomised trials

Mike Clarke, Luc Bijnens, Michael Gnant, 1998, The Lancet.